These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

885 related items for PubMed ID: 26282231

  • 1. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J, Huang Q, Long X, Zhang J, Huang X, Aa J, Yang H, Chen Z, Xing J.
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [Abstract] [Full Text] [Related]

  • 2. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W, Xiang W, Han L, Yuan Z, Wang R, Ma Y, Yang Y, Cai S, Xu Y, Mo S, Li Q, Cai G.
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [Abstract] [Full Text] [Related]

  • 3. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C, Wu M, Liu H, Ren Y, Du Y, Wu H, Wei J, Liu C, Yao F, Wang H, Zhu Y, Duan H, Shi Y.
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [Abstract] [Full Text] [Related]

  • 4. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M.
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [Abstract] [Full Text] [Related]

  • 5. Genistein Regulates Lipid Metabolism via Estrogen Receptor β and Its Downstream Signal Akt/mTOR in HepG2 Cells.
    Qin H, Song Z, Shaukat H, Zheng W.
    Nutrients; 2021 Nov 10; 13(11):. PubMed ID: 34836271
    [Abstract] [Full Text] [Related]

  • 6. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
    Wu D, Yang Y, Hou Y, Zhao Z, Liang N, Yuan P, Yang T, Xing J, Li J.
    Cancer Commun (Lond); 2022 Jan 10; 42(1):37-55. PubMed ID: 34981667
    [Abstract] [Full Text] [Related]

  • 7. Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma.
    Li X, Zhang Y, Ma W, Fu Q, Liu J, Yin G, Chen P, Dai D, Chen W, Qi L, Yu X, Xu W.
    Cancer Immunol Immunother; 2020 Apr 10; 69(4):535-548. PubMed ID: 31965268
    [Abstract] [Full Text] [Related]

  • 8. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
    Chen J, Ding C, Chen Y, Hu W, Yu C, Peng C, Feng X, Cheng Q, Wu W, Lu Y, Xie H, Zhou L, Wu J, Zheng S.
    Cancer Lett; 2021 Apr 01; 502():154-165. PubMed ID: 33340617
    [Abstract] [Full Text] [Related]

  • 9. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
    López-Oliva ME, Garcimartin A, Muñoz-Martínez E.
    Br J Nutr; 2017 Dec 01; 118(11):914-929. PubMed ID: 29173234
    [Abstract] [Full Text] [Related]

  • 10. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
    Yu X, Lin Q, Wu Z, Zhang Y, Wang T, Zhao S, Song X, Chen C, Wang Z, Xu L, Li C, Gao L, Liang X, Yue X, Ma C.
    J Pathol; 2020 Dec 01; 252(4):358-370. PubMed ID: 32770671
    [Abstract] [Full Text] [Related]

  • 11. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway.
    Zhao J, Zhang X, Gao T, Wang S, Hou Y, Yuan P, Yang Y, Yang T, Xing J, Li J, Liu S.
    Cell Death Dis; 2020 Jan 13; 11(1):25. PubMed ID: 31932581
    [Abstract] [Full Text] [Related]

  • 12. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L, Fang K, Dan X, Gu M.
    Lipids Health Dis; 2019 Jan 08; 18(1):11. PubMed ID: 30621686
    [Abstract] [Full Text] [Related]

  • 13. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
    Wang C, Chen Z, Yi Y, Ding Y, Xu F, Kang H, Lin K, Shu X, Zhong Z, Zhang Z, Liu J, Xu Z, Liu L, He X, Chang Y, Zhao Q.
    Oncogene; 2024 Jan 08; 43(5):328-340. PubMed ID: 38040804
    [Abstract] [Full Text] [Related]

  • 14. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
    Huang Q, Li J, Xing J, Li W, Li H, Ke X, Zhang J, Ren T, Shang Y, Yang H, Jiang J, Chen Z.
    J Hepatol; 2014 Oct 08; 61(4):859-66. PubMed ID: 24801417
    [Abstract] [Full Text] [Related]

  • 15. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
    Jin J, Wang SJ, Cui J, Li L, Li JY, Liu FL, Sun XX, Jiang JL, Cui HY, Chen ZN.
    Cell Oncol (Dordr); 2019 Aug 08; 42(4):537-554. PubMed ID: 31016558
    [Abstract] [Full Text] [Related]

  • 16. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
    Liu Y, Wang F, Yan G, Tong Y, Guo W, Li S, Qian Y, Li Q, Shu Y, Zhang L, Zhang Y, Xia Q.
    Cancer Lett; 2024 Jul 28; 595():217006. PubMed ID: 38823763
    [Abstract] [Full Text] [Related]

  • 17. LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.
    Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH.
    World J Gastroenterol; 2019 Dec 07; 25(45):6607-6618. PubMed ID: 31832001
    [Abstract] [Full Text] [Related]

  • 18. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J, Lu M, Li Y, Shang YK, Wang SJ, Meng Y, Wang Z, Li ZS, Chen H, Chen ZN, Bian H.
    Oncogene; 2016 Oct 20; 35(42):5468-5479. PubMed ID: 27041581
    [Abstract] [Full Text] [Related]

  • 19. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
    Bai PS, Xia N, Sun H, Kong Y.
    J Cell Mol Med; 2017 Nov 20; 21(11):3023-3043. PubMed ID: 28557334
    [Abstract] [Full Text] [Related]

  • 20. Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
    Hu J, Che L, Li L, Pilo MG, Cigliano A, Ribback S, Li X, Latte G, Mela M, Evert M, Dombrowski F, Zheng G, Chen X, Calvisi DF.
    Sci Rep; 2016 Feb 09; 6():20484. PubMed ID: 26857837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.